Whooping cough vaccine is less effective because of bacterial mutation, study finds



[ad_1]

Breaking News Emails

Receive last minute alerts and special reports. News and stories that matter, delivered in the morning on weekdays.

By Erika Edwards

The pertussis vaccine is not working as well as it has before, and new research suggests that it is largely due to the fact that the bacterium that caused the disease has mutated.

Researchers from the Centers for Disease Control and Prevention analyzed laboratory samples from whooping cough patients between 2000 and 2013 and found that Bordetella pertussis, which causes whooping cough, has undergone genetic changes over time.

This means that the current vaccine does not perfectly match the bacteria. The researchers hope the new data released Wednesday in Emerging Infectious Diseases will help change that.

"The genomic data we provide will help open research to improve vaccine development and disease control strategies," the CDC authors wrote in their report.

The experts in infectious diseases agree.

"The pertussis vaccine is not optimal," said Dr. William Schaffner, professor of preventive medicine at the Vanderbilt University Medical Center.

"We are making the best use of the vaccine, as we do frenzied research to improve the vaccine," said Schaffner. But a new pertussis vaccine is far from ready, he said.

Babies are most at risk

Everyone can have whooping cough, but newborns are the most vulnerable.

Babies and children are currently receiving a vaccine called DTaP. It is a vaccine that protects against three diseases: whooping cough, diphtheria and tetanus. Studies have shown that the vaccine is safe and that it works very well against diphtheria and tetanus, protecting almost all those who contract it for a decade.

[ad_2]

Source link